🇺🇸 Intravenous Dexmedetomidine infusion in United States

Intravenous Dexmedetomidine infusion (Intravenous Dexmedetomidine infusion) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Intravenous Dexmedetomidine infusion in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Intravenous Dexmedetomidine infusion approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Intravenous Dexmedetomidine infusion in United States?

Shaheed Mohtarma Benazir Bhutto Institue of Trauma is the originator. The local marketing authorisation holder may differ — check the official source linked above.